首页|Structural revision and pharmacological activity of hemslecin C
Structural revision and pharmacological activity of hemslecin C
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Sage
Hemslecin C, a compound with a novel skeleton, is synthesized by refluxing hemslecin A with KOH in alcohol. Hemslecin C was structurally characterized by specific optical rotation measurement, high-resolution mass spectroscopy, and nuclear magnetic resonance spectroscopic analysis. In addition, the molecular structure of hemslecin C was unambiguously determined by X-ray single-crystal determination. We found that its structure was different from that reported in the literature. The acetyl group of hemslecin A is transferred to the carbonyl alpha carbon of the side chain and is attacked by the 22-hydroxyl group to give a hemi-acetal that is dehydrated to give hemslecin C. The anticancer activity of this new skeleton is determined by sulforhodamine B assay method, and demonstrates excellent activity, thus providing a new framework for the development of anticancer drugs.
anticancer activitycrystal structurehemslecin Csulforhodamine B assay
NSTL
Sage
